"Designing Growth Strategies is in our DNA"

North America Osteoporosis Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Bisphosphonate, Hormone Replacement Therapy, Selective Estrogen Receptor Modulator (SERMs), RANK ligand (RANKL) Inhibitor, and Others), By Route of Administration (Oral, and Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, and Online Pharmacies) and Forecast, 2020-2027

Region : North America | Format: PDF | Report ID: FBI104867

 

Table of Content:

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Osteoporosis, Key Countries, 2019
    2. Technology Advances, Osteoporosis Market
    3. New Product Launches, Key Players
    4. Key Developments, Mergers, Acquisitions, etc.
    5. Impact of Covid-19 on the Market
  5. North America Osteoporosis Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Bisphosphonate
      2. Hormone Replacement Therapy
      3. Selective Estrogen Receptor Modulator (SERMs)
      4. RANK ligand (RANKL) Inhibitor
      5. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Cardiovascular
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  6. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Company Profiles (Overview, Products, SWOT, Recent Developments, Strategies, Financials (based on availability))
      1. AbbVie Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      2. Eli Lilly and Company
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      3. Amgen Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      4. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      5. Novartis AG
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      6. Sanofi
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      7. Pfizer Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      8. Merck & Co., Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      9. GlaxoSmithKline plc
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      10. Alcon
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      11. Other Prominent Player
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
  7. Strategic Recommendations

List of Figures

Figure 01: North America Osteoporosis Treatment Market Revenue Breakdown (USD billion, %) by Region, 2019 & 2027

Figure 02: North America Osteoporosis Treatment Market Value Share (%), by Technology, 2019 & 2027

Figure 03: North America Osteoporosis Treatment Market Forecast (USD billion), By Bisphosphonate, 2016-2027

Figure 04: North America Osteoporosis Treatment Market Forecast (USD billion), By Hormone Replacement Therapy, 2016-2027

Figure 05: North America Osteoporosis Treatment Market Forecast (USD billion), By Selective Estrogen Receptor Modulator (SERMs), 2016-2027

Figure 06: North America Osteoporosis Treatment Market Forecast (USD billion), By RANK ligand (RANKL) Inhibitor, 2016-2027

Figure 07: North America Osteoporosis Treatment Market Forecast (USD billion), By Others, 2016-2027

Figure 08: North America Osteoporosis Treatment Market Value Share (%), by Route of Administration, 2019 & 2027

Figure 09: North America Osteoporosis Treatment Market Forecast (USD billion), By Oral, 2016-2027

Figure 10: North America Osteoporosis Treatment Market Forecast (USD billion), By Parenteral, 2016-2027

Figure 11: North America Osteoporosis Treatment Market Value Share (%), by Distribution Channel, 2019 & 2027

Figure 12: North America Osteoporosis Treatment Market Forecast (USD billion), By Hospitals Pharmacies, 2016-2027

Figure 13: North America Osteoporosis Treatment Market Forecast (USD billion), By Retail Pharmacies & Stores, 2016-2027

Figure 14: North America Osteoporosis Treatment Market Forecast (USD billion), By Online Pharmacies, 2016-2027

Figure 15: North America Osteoporosis Treatment Market Value (USD billion), by Country, 2019 & 2027

List of Tables

Table 01: North America Osteoporosis Treatment Market Revenue (USD billion) Forecast, By Drug Class, 2016-2027

Table 02: North America Osteoporosis Treatment Market Revenue (USD billion) Forecast, By Route of Administration, 2016-2027

Table 03: North America Osteoporosis Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2016-2027

Table 04: North America Osteoporosis Treatment Market Revenue (USD billion) Forecast, by Country, 2016-2027

 class=
  • Feb, 2021
  • 2019
  • 2016-2018
  • 24

    CHOOSE LICENSE TYPE

  • 3850
    5850
    7850

Healthcare Clients

DUPONT
Abbott
baxter
lpsos
Logo_Merck_KGaA_2015
chong-kun-dang
DAEWOONG
Natus-Medical
SUANFARMA
Bio-Rad
Intuitive_Surgical_logo
novo-nordisk
Ge-Healthcare
Sedana-Cyan-Black-Tag

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X